Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CYP4Z1 | Q86W10 | 5/20 | 0.38 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.37 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.37 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.37 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | ADH1B | P00325 | 1/20 | 0.33 |
| ▸ | ADH1C | P00326 | 1/20 | 0.33 |
| ▸ | ADH1A | P07327 | 1/20 | 0.33 |
| ▸ | ADH4 | P08319 | 1/20 | 0.33 |
| ▸ | ADH7 | P40394 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | DNM2 | P50570 | 2/20 | 0.32 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.31 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.31 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1824038 | 0.71 | CYP4Z1 (0.41) | ALDH1A1TSHRCYP4Z1GNAI3GNAO1 | |
| SCHEMBL529880 | 0.71 | TBXAS1 (0.47) | ALDH1A1TSHRCYP4Z1GNAI3GNAO1 | |
| SCHEMBL21796145 | 0.70 | CYP4Z1 (0.43) | CYP4Z1GNAI3GNAO1GNAI1EPHX1 | |
| SCHEMBL28881459 | 0.70 | TBXAS1 (0.50) | ALDH1A1TSHRCYP4Z1GNAI3GNAO1 | |
| SCHEMBL10770404 | 0.70 | TBXAS1 (0.50) | ALDH1A1TSHRCYP4Z1GNAI3GNAO1 | |
| SCHEMBL11883639 | 0.68 | ALDH1A1 (0.40) | ALDH1A1TSHRCYP4Z1GNAI3GNAO1 | |
| SCHEMBL515050 | 0.67 | CYP4Z1 (0.37) | ALDH1A1TSHRCYP4Z1GNAI3GNAO1 | |
| SCHEMBL8665131 | 0.64 | GNAI3 (0.67) | ALDH1A1TSHRCYP4Z1GNAI3GNAO1 | |
| SCHEMBL4317994 | 0.64 | TBXAS1 (0.43) | ALDH1A1TSHRTBXAS1 | |
| Dipentylamine SCHEMBL62012 | 0.59 | TSHR (1.00) | ALDH1A1TSHREPHX1ADH1BADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10576148-B2 | Use of VAP-1 inhibitors for treating fibrotic conditions | BIOTIE THERAPIES CORP. (FI) | 2020-03-03 | — | — | US | disclosed |
| US-20180071388-A1 | USE OF VAP-1 INHIBITORS FOR TREATING FIBROTIC CONDITIONS | BIOTIE THERAPIES CORP. (FI) | 2018-03-15 | — | — | US | disclosed |
| EP-2475387-B1 | VAP-1 INHIBITORS FOR USE IN TREATING FIBROTIC CONDITIONS | BIOTIE THERAPIES CORP (FI) | 2017-11-01 | — | — | EP | disclosed |
| US-9795671-B2 | Use of VAP-1 inhibitors for treating fibrotic conditions | BIOTIE THERAPIES CORP. (FI) | 2017-10-24 | — | — | US | disclosed |
| US-20130195883-A1 | USE OF VAP-1 INHIBITORS FOR TREATING FIBROTIC CONDITIONS | THE UNIVERSITY OF BIRMINGHAM (GB) | 2013-08-01 | — | — | US | disclosed |
| EP-2475387-A1 | USE OF VAP-1 INHIBITORS FOR TREATING FIBROTIC CONDITIONS | Biotie Therapies Corp. (FI) | 2012-07-18 | — | — | EP | disclosed |
| WO-2011029996-A1 | USE OF VAP-1 INHIBITORS FOR TREATING FIBROTIC CONDITIONS | BIOTIE THERAPIES CORP. (FI) | 2011-03-17 | — | — | WO | disclosed |